Large CROs operate with a one-size fits all approach, when this no longer worked for a late-stage clinical biopharmaceutical company, they turned to Catalyst Flex to design a tailored solution to meet the safety needs of this rescue study.
Image Credit: © peshkova – stock.adobe.com An overwhelming amount of cancer patients express willingness to participate in clinical trials; however, only a small portion will […]
Image credit: JHVEPhoto | stock.adobe.com The FDA has notified Moderna that it will be unable to finish reviewing its Biologics License Application (BLA) for the […]
Image Credit: © VadimGuzhva – stock.adobe.com Pfizer announced it has selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor […]